Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px
Document › Details

Novartis AG. (4/24/19). "Press Release: Novartis Starts 2019 with Strong Sales and Double Digit Core Operating Income Growth, Mayzent Launch and Alcon Spin-off, Profit Guidance Upgraded". Basel.

Organisations Organisation Novartis AG (NYSE: NVS)
  Group Novartis (Group)
  Organisation 2 Alcon (Group)
  Today Alcon, division of Novartis
  Group Novartis (Group)
Products Product Mayzent
  Product 2 Zolgensma®
Persons Person Narasimhan, Vasant (Vas) (Novartis 201408– Global Head Developm Novartis Pharma before Global Head Developm Vaccines
  Person 2 Saynor, Richard (Novartis 2019Q1– CEO of Sandoz)
     


   
Record changed: 2019-04-30

Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

More documents for Novartis (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px




» top